• CellTient technology is unique. Over the past 40 years, cellular analysis has been focused on finding cells but the level of analysis is low. WWhen it comes to very small particles, current technologies like flow cytometry simply cannot make accurate measurements.
  • CellTient has revolutionized the process of detecting the smallest particles in blood. These particles are now known to provide a great deal of information such as the early detection of cancers and also there is evidence that detecting these particles can be a strong indicator of cardiac disease.
  • CellTient has also developed new analytical systems that can translate these tiny particles into well documented particle identities. This is achieved by tagging these particles using fluorescent conjugated targeting antibodies.
    • We have access to a new SiPM sensor with extraordinary sensitivity and extremely low noise recently developed by one of CellTient’s sister companies. This new sensor technology gives unparalled performance in single photon detection.